Lucid Diagnostics(LUCD) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results Processed 2,756 EsoGuard tests and recognized 2Q25 revenue of $1.2 million, ending quarter with over $30 million in proforma cash and extending runway well past upcoming reimbursement milestones Multi-Jurisdictional Contractor Advisory Committee (CAC) meeting on Medicare Local Coverage Determination (LCD) for EsoGuard to be held on September 4 Conference call and webcast to be held today, August 13, at ...